Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevnar and Pneumovax in liver transplant recipients
NCT00152802Phase 4Unknown
- Sponsor
- University Health Network
- Start
- Jan 2005
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection, sponsored by University Health Network. Primary endpoint: Anticapsular antibody concentration at 16 weeks. Status: unknown.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00152802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152802.